Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 3 (2), 149-153
- https://doi.org/10.1016/s0168-8278(86)80020-4
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosisGastroenterology, 1985
- Mitozantrone as single agent therapy in hepatocellular carcinomaJournal of Hepatology, 1985
- Primary liver cancer. An eastern cooperative oncology group trialCancer, 1984
- Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapyCancer, 1984
- Serum bilirubin: a prognostic factor in primary biliary cirrhosis.Gut, 1979
- Chemotherapy studies in primary liver cancer. A prospective randomized clinical trialCancer, 1978
- Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology reportCancer, 1978
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United StatesCancer, 1977
- Treatment of hepatocellular carcinoma with adriamycin.Preliminary communicationCancer, 1975